Who will win this year’s MassChallenge? The Boston accelerator is set to get its fourth session underway with the announcement of the 128 new startups that will participate. A quarter of them are life science or health IT companies, and some of them sound particularly promising.
Benevolent Technology for Health, for example, is focused on making an affordable, self-adjustable prosthetic device for the developing world. DS Labs Inc. is developing a discreetly worn breast pump. Sensulin LLC could have a glucose-responsive insulin for type 1/type 2 diabetes patients. And Vecoy Nanomedicines won the pitch contest at FutureMed with its nano-scale “virus traps” to kill infections.
